The NHS in England will be the first health system in the world to roll-out a ‘trojan horse’ targeted therapy for blood cancer patients which could halt the disease’s progression by nearly three times ...

It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...

It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...

GSK is putting the finishing touches on its case for antibody-drug conjugate Blenrep with a key progression-free survival ...

GSK said it licensed its Shigella vaccine candidate, altaltSonflex1-2-3, to Bharat Biotech International.

Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...

Several vaccine maker stocks slipped in after-hours trading Monday after Health Secretary Robert F. Kennedy Jr. announced a ...

Volunteers from GSK helped to paint the garden furniture and fences at Elmhurst to improve the experience for residents at ...

GlaxoSmithKline purchased Corixa, a biotech company with offices in South San Francisco, Seattle and Hamilton, for about $300 million. No details were available over the weekend about potential ...

The 12-year-old company had been collaborating with British pharmaceutical giant GlaxoSmithKline on an immuno-oncology drug ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...